Dr Scott Gottlieb Says FDA Is Monitoring Drug Device Production in Puerto Rico

October 21, 2017
The Center for Biosimilars Staff

In addition to challenges related to reliable power, connectivity, transportation, and clean water, Puerto Rico

On Friday, FDA Commissioner Scott Gottlieb, MD,

Related Content:

News | Regulatory | Policy | Business